InSimili s.r.l. is a private biotechnology company that aims to bring to the market a patented technology, which will revolutionize the drug selection process. Our product is able to recreate, in the laboratory experiments, several pathological and physiological conditions of human tissues. This feature enables in vitro drug testing in an environment which is much closer to the one of human tissues, where the drug has to effectively work. This approach will enable a better evaluation of the real efficacy of pharmacological treatments, limiting the number of drugs wrongly selected in the preclinical phase and, as a consequence, reducing the failures in the clinical phases. This approach will make the drug selection process faster, more efficient and more safe in respect to the actually adopted procedures.